About Adelaide Eye and Retina Centre
Clinical Trials at Adelaide Eye and Retina Centre
During the past decade, Adelaide Eye and Retina Centre conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Adelaide Eye and Retina Centre" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials
sponsored, "Exonate Limited" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Ripple Therapeutics Pty Ltd"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Adelaide Eye and Retina Centre"
#1 collaborator was "Novotech (Australia) Pty Limited" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Adelaide Eye and Retina Centre
According to Clinical.Site data, the most researched conditions in "Adelaide Eye and Retina Centre" are
"Geographic Atrophy" (2 trials), "Diabetic Macular Edema" (1 trials), "Diabetic Macular Oedema" (1 trials), "Diabetic Retinopathy" (1 trials) and "Low-grade Serous Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "Adelaide Eye and Retina Centre" in a lesser frequency.
Clinical Trials Intervention Types at Adelaide Eye and Retina Centre
Most popular intervention types in "Adelaide Eye and Retina Centre" are "Drug" (5 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "BI 765128" (1 trials), "EXN407" (1 trials), "IBE-814 140ug" (1 trials), "IBE-814 70ug" (1 trials) and "Lampalizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Adelaide Eye and Retina Centre
The vast majority of trials in "Adelaide Eye and Retina Centre" are
5 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Adelaide Eye and Retina Centre
Currently, there are NaN active trials in "Adelaide Eye and Retina Centre".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Adelaide Eye and Retina Centre,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Adelaide Eye and Retina Centre, 2 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".